2024-07-31-accounts - Association For The Global Advancement Of Ent Surgery And Head And Neck Cancer Research

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Trustees’ Annual Report for the period

From 25/7/2023 Period start date To 31/7/2024 Period end date

Charity name: ASSOCIATION FOR THE GLOBAL ADVANCEMENT OF ENT SURGERY AND HEAD AND NECK CANCER RESEARCH

Charity registration number: 1165453

Objectives and Activities

	SORP reference
Summary of the purposes of the charity as set out in its governing document	Para 1.17	The advancement of health and relief of sickness in the field of ear, nose and throat/head and neck surgery and head and neck disorders across the world in particular but not exclusively by: · Supporting the provision of awareness and screening programmes · Supporting cancer research by the provision of grants (AGA-ENT Charity Governing document - version 1.1-21/1/2016)
Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts.	Para 1.17 and 1.19	· Supporting the provision of awareness and screening programmes · Supporting cancer research by the provision of grants and support for UK and international research
Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit	Para 1.18	Yes, the trustees have had regard.

Additional information (optional)

You may choose to include further statements where relevant about:

SORP reference N/A Para 1.38 Policy on grant making N/A Para 1.38 Policy on social investment including program related investment

Contribution made by volunteers	Para 1.38	Minor contributions, e.g. help with social media.
Other		N/A

Achievements and Performance

	SORP reference
Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole.	Para 1.20	Our work has unfortunately been affected by the pandemic, but we have continued the fundraising in order to get the programme established fully in 2023/4 again. We have supported fellows with grants in the past and the travel fellowships which had been awarded will now be utilised in line with the aims and objectives of the charity and continue to be awarded for 2024. After our BICRAA app (www.bicraa.org) had been successfully tested in India (n=1049), showing that around 30% chew betel nut (we would like to thank Prof. Kelkar and Dr. Pethe from the Deenanath Mangeshkar Hospital, Pune, for their invaluable support), the app has continued to help raise the awareness of the risks of betel nut chewing. We have continued working on a global study to extend these efforts in India and other countries. With regard to our work in Indonesia, we have continued to closely work with our partners at the Dr. Sardjito Hospital/Gadjah Mada University in Yogyakarta, Indonesia, and one of the trustees, Mr. Matt Lechner, travelled there in September 2022 to support the local Nasopharyngeal Cancer (NPC) awareness and early detection programme and to support research and publications of results. The Storz company has continued to support our programme and in 2024 we were will be able to award fellowship grants to young surgeons, sponsored by a donation by Storz, allowing them travel to low and middle income countries and to help with the local charitable work.

Additional information (optional)

You may choose to include further statements where relevant about:

Achievements against objectives set	Para 1.41	As above. Taking the above work into account AGA-ENT has made contributions to the advancement of health and relief of sickness in the field of ear, nose and throat/head and neck surgery and head and neck disorders in low and middle income countries. However, our work has unfortunately been affected by the pandemic, but we have aimed to continue the fundraising in order to get the programme established fully in 2024. Held Annual Awards 2024.
Performance of fundraising activities against objectives set	Para 1.41	Good progress. Substantive funding will be sought once the preliminary data are published.
Investment performance against objectives	Para 1.41	N/A
Other		N/A

Financial Review

Financial Review
Review of the charity’s financial position at the end of the period	Para 1.21	31/7/2024
Statement explaining the policy for holding reserves stating why they are held	Para 1.22	Year on year the charity hopes to increase the reserves to be consistently in line with 2 years possible commitments
Amount of reserves held	Para 1.22	£15,660
Reasons for holding zero reserves	Para 1.22	N/A
Details of fund materially in deficit	Para 1.24	N/A
Explanation of any uncertainties about the charity continuing as a going concern	Para 1.23	N/A

Additional information (optional)

You may choose to include further statements where relevant about:

The charity’s principal sources of funds (including any fundraising)	Para 1.47	Donations by private and charity donors and donated equipment.
Investment policy and objectives including any social investment policy adopted	Para 1.46	N/A
A description of the principal risks facing the charity	Para 1.46	At present funds are sufficient to achieve the aims set, but more funding needs to be sought to continue to expand our work. Ensuring the ongoing income is the most important risk we manage.
Other		N/A

Structure, Governance and Management

Description of charity’s trusts:
Type of governing document (trust deed, royal charter)	Para 1.25	Constitution of the Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research (AGA- ENT), a Charitable Incorporated Organisation with voting members other than its charity trustees Date of constitution (last amended): 21/01/2016 (AGA-ENT Charity Governing document - version 1.1 - 21/1/2016)
How is the charity constituted? (e.g unincorporated association, CIO)	Para 1.25	Charitable Incorporated Organisation
Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees	Para 1.25	The current trustees volunteered to take on these roles with the support of all founding members and fulfil these roles in line with the duties outlined in the AGA-ENT Charity Governing document - version 1.1 - 21/1/2016

Additional information (optional)

You may choose to include further statements where relevant about:

Policies and procedures adopted for the induction and training of trustees	Para 1.51	All duties outlined in the AGA-ENT Charity Governing document - version 1.1 - 21/1/2016 and discussed during regular Trustees’ meetings.
The charity’s organisational structure and any wider network with which the charity works	Para 1.51	Charitable Incorporated Organisation with voting members other than its charity trustees
Relationship with any related parties	Para 1.51	Collaborators and partners globally who help to achieve the outlined objectives, usually within the network of Founding Members.
Other		N/A

Reference and Administrative details

Charity name Association for the Global Advancement of ENT Surgery and - Head and Neck Cancer Research (AGA ENT) Other name the charity uses AGA-ENT Registered charity number 1165453

Charity’s principal address	Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research (AGA-ENT), 4th Floor, Eldon Chambers, 30-32 Fleet Street, London, EC4Y 1AA.

Names of the charity trustees who manage the charity

Trustee name	Dates acted if not for whole year	Name of person (or body) entitled to appoint trustee (ifany)
Paul O’Flynn	5/2/2016 – current date	Membershipbody
Matt Lechner	5/2/2016 – current date	Membershipbody
Valerie J. Lund	5/2/2016 – current date	Membershipbody
Francis M. Vaz	5/2/2016 – current date	Membershipbody

– Corporate trustees names of the directors at the date the report was approved Director name N/A

Name of trustees holding title to property belonging to the charity

Trustee name	Dates acted if not for whole year
N/A

Funds held as custodian trustees on behalf of others

Description of the assets None held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets

Additional information (optional)

Names and addresses of advisers (Optional information)

Names and addresses of advisers (Optional information)	Names and addresses of advisers (Optional information)	Names and addresses of advisers (Optional information)
Type of adviser Name Address
N/A



Name of chief executive or names of senior staff members (Optional information)
N/A

N/A

Exemptions from disclosure

Reason for non-disclosure of key personnel details

The charity is too small still to employ personnel

Other optional information

N/A

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Mr. Matt Lechner Position (eg Secretary, Trustee Chair, etc) Date 07/02/2025

Association for the Global Advancement of ENT Surgery 1165453 and Head and Neck Cancer Research Receipts and payments accounts CC16a For the period 25/07/2023 To 31/07/2024 from

Section A Receipts and payments

A1 Receipts	Unrestricted funds to the nearest £ 104,585 - - 9 - - - - 104,594 - - - 104,594 61 899 91,296 - 113 - 690 - - 93,058	Restricted funds to the nearest £ - - - - - - - - - - - - - - - - - - - - - -	Endowment funds to the nearest £ - - - - - - - - - - - - - - - - - - - - - -	Total funds to the nearest £ 104,585 - - 9 - - - - 104,594 - - - 104,594 61 899 91,296 - 113 - 690 - - 93,058	Last year to the nearest £
Donations	104,585				1,743
	-
	-				-
Bank interest	9				5
	-				-
	-				-
	-				-
	-				-
*Sub total*(Gross income for AR)	104,594				1,748

A2 Asset and investment sales, (see table).
	-
	-				-
*Sub total*	-				-
*Total receipts* A3 Payments
					1,748

Fundraisingcosts	61	-	-	61	134
Web hostingand website costs	899	-	-	899	40
Fellowships and Grants	91,296	-	-	91,296	5,000
FundingApplication	-	-	-	-	-
Office costs	113	-	-	113	213
Travel expenses re: researchgrant	-			-	732
Legal andprofessional fees	690	-	-	690	690
Sundryexpenses	-	-	-	-	-
	-	-	-	-	-
**Sub total **	93,058	-	-	93,058	6,809

Sundryexpenses **Sub total **	- - 93,058	- - -	- - -		- - 93,058	- - 6,809
A4 Asset and investment
purchases, (see table)
	-	-		-	-
	-	-		-	-
**Sub total **	-	-		-	-	-

*Total payments*	93,058	-		-	93,058	6,809
*Net of receipts/(payments)*	11,536	-		-	11,536	- 5,062
A5 Transfers between funds	-	-	-		-	-
A6 Cash funds last year end	4,124	-	-		4,124	9,186
*Cash funds this year end*	15,660	-		-	15,660	4,124

Section B Statement of assets and liabilities at the end of the period

*Total cash funds* (agree balances with receipts and payments account(s)) Details Details Bank accounts	*Total cash funds* (agree balances with receipts and payments account(s)) Details Details Bank accounts	Unrestricted funds to nearest £ 15,660 - - 15,660 OK Unrestricted funds to nearest £	Restricted funds to nearest £ - - - - OK Restricted funds to nearest £	Endowment funds to nearest £
				-
				-
				-
				-
				OK
				Endowment funds to nearest £
		-	-	-
		-	-	-
		-	-	-
		-	-	-
		-	-	-
		-	-	-
Signature Details Details Details Matt Lechner (Feb 7, 2025 17:54 GMT)		Fund to which asset belongs Cost (optional) - - - - - Fund to which asset belongs Cost (optional) - - - - - - - - - Fund to which liability relates Amount due (optional) - - - - Print Name M Lechner		Current value (optional)
				-
				-
				-
				-
				-
				Current value (optional)
				-
				-
				-
				-
				-
				-
				-
				-
				-
				When due (optional)






				Date of approval
	Matt Lechner (Feb 7, 2025 17:54 GMT)	M Lechner		07/02/25

Signed by one or two trustees on behalf of all the trustees

AGA-ENT - CC16a - Accounts - y.e 31.07.24

Final Audit Report 2025-02-07

Created: 2025-02-07 By: Michelle Cox (michelle@kershen-fairfax.com) Status: Signed Transaction ID: CBJCHBCAABAAc1u5ZD8wN2WUynsCfcL2zgg2BPvhDpEj

"AGA-ENT - CC16a - Accounts - y.e 31.07.24" History

Document created by Michelle Cox (michelle@kershen-fairfax.com)

2025-02-07 - 5:06:10 PM GMT

Document emailed to Matt Lechner (dr.matt.lechner@gmail.com) for signature 2025-02-07 - 5:06:14 PM GMT

Email viewed by Matt Lechner (dr.matt.lechner@gmail.com) 2025-02-07 - 5:53:34 PM GMT

Document e-signed by Matt Lechner (dr.matt.lechner@gmail.com) Signature Date: 2025-02-07 - 5:54:04 PM GMT - Time Source: server

Agreement completed.

2025-02-07 - 5:54:04 PM GMT

Independent examiner's report on the accounts

Section A Independent Examiner’s Report

Report to the trustees/ members of

Charity Name

Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research

On accounts for the year ended

31[st] July 2024

Charity no (if any)

1165453

Set out on pages

1-2

(remember to include the page numbers of additional sheets)

Responsibilities and basis of report

I report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the year ended 31/07/2024.

As the charity trustees of the Trust, you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (“the Act”).

I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent examiner's statement

I have completed my examination. I confirm that no material matters have come to my attention (other than that disclosed below *) in connection with the examination which gives me cause to believe that in, any material respect:

accounting records were not kept in accordance with section 130 of the Act or
the accounts do not accord with the accounting records

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in order to enable a proper understanding of the accounts to be reached. * Please delete the words in the brackets if they do not apply.

Signed:

Date:

07/02/2025

Name:

M D Cox

Relevant professional qualification(s) or body (if any):

October 2018

IER

ACA FCCA

Address:

c/o Kershen Fairfax Ltd, 4[th] Floor, Eldon Chambers

30-32 Fleet Street, London

EC4Y 1AA

Section B Disclosure

Only complete if the examiner needs to highlight matters of concern (see CC32, Independent examination of charity accounts: directions and guidance for examiners).

Give here brief details of any items that the examiner wishes to disclose .

October 2018

IER